PDS Biotechnology Corp Net Income Loss

• PDS Biotechnology Corp showed an increase of +8.3% in Net Income Loss from 2024 to 2025.
• This data is from PDS Biotechnology Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 13 years of available data (2013 to 2025), PDS Biotechnology Corp's Net Income Loss has declined by 401.2%.
• Historical annual values: Fiscal year 2025: -$34.50 million | Fiscal year 2024: -$37.61 million | Fiscal year 2023: -$42.94 million | Fiscal year 2022: -$40.85 million | Fiscal year 2021: -$16.92 million | Fiscal year 2020: -$14.85 million | Fiscal year 2019: -$7.00 million | Fiscal year 2018: -$3.84 million | Fiscal year 2017: -$50.86 million | Fiscal year 2016: -$38.82 million | Fiscal year 2015: -$28.08 million | Fiscal year 2014: -$12.20 million | Fiscal year 2013: -$6.88 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026